Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Livmed's is a software platform that provides home medicine delivery services for fellow citizens and healthcare players.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
EuroAPI develops, manufactures and supplies the active-ingredient solutions for healthcare.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Rology is an AI-assisted On-demand Teleradiology Platform.
Sanofi has invested in 131 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, EuroAPI received $825.5M in a Post-IPO Debt round. Sanofi's total known invested capital is $6.2B.
Sanofi's average investment size is $117.1M across its portfolio of 131 companies.
Recent Sanofi portfolio additions include Alveus Therapeutics, InduPro, Enable Injections, Atalanta Therapeutics, Graviton Bioscience. These companies were founded in 2020 or later.